These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12109337)

  • 61. Chemoprevention of prostate cancer: the Prostate Cancer Prevention Trial.
    Thompson IM; Coltman CA; Crowley J
    Prostate; 1997 Nov; 33(3):217-21. PubMed ID: 9365551
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
    Hoque A; Albanes D; Lippman SM; Spitz MR; Taylor PR; Klein EA; Thompson IM; Goodman P; Stanford JL; Crowley JJ; Coltman CA; Santella RM
    Cancer Causes Control; 2001 Sep; 12(7):627-33. PubMed ID: 11552710
    [TBL] [Abstract][Full Text] [Related]  

  • 63. First International Conference on Chemoprevention of Prostate Cancer. Overview consensus statement.
    Thompson IM; Albanes D; Basler JW; Crawford ED; Denis LJ; Djavan B; Fleshner N; Johnson-Pais TL; Klein EA; Kristal AR; Lucia MS; Parnes HL; Piazza GA; Platz EA; Pollock BH; Price DK; Reichardt JK; Tangen CM; Tolcher AW; McMann MC
    J Urol; 2004 Feb; 171(2 Pt 2):S3-4. PubMed ID: 14713744
    [No Abstract]   [Full Text] [Related]  

  • 64. Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium.
    Fleshner NE; Kapusta L; Donnelly B; Tanguay S; Chin J; Hersey K; Farley A; Jansz K; Siemens DR; Trpkov K; Lacombe L; Gleave M; Tu D; Parulekar WR
    J Clin Oncol; 2011 Jun; 29(17):2386-90. PubMed ID: 21537051
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prospective evaluation of two recruitment strategies for a randomized controlled cancer prevention trial.
    Chlebowski RT; Menon R; Chaisanguanthum RM; Jackson DM
    Clin Trials; 2010 Dec; 7(6):744-8. PubMed ID: 20833684
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Selenium in complementary oncology. A critical comments on the SELECT trial].
    Gröber U
    Med Monatsschr Pharm; 2010 Apr; 33(4):140-2. PubMed ID: 20429404
    [No Abstract]   [Full Text] [Related]  

  • 67. Is There a Future for Chemoprevention of Prostate Cancer?
    Bosland MC
    Cancer Prev Res (Phila); 2016 Aug; 9(8):642-7. PubMed ID: 27099271
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk.
    Kirsh VA; Hayes RB; Mayne ST; Chatterjee N; Subar AF; Dixon LB; Albanes D; Andriole GL; Urban DA; Peters U;
    J Natl Cancer Inst; 2006 Feb; 98(4):245-54. PubMed ID: 16478743
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
    Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S
    Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of supplemental vitamins and minerals on the development of prostate cancer: a systematic review and meta-analysis.
    Stratton J; Godwin M
    Fam Pract; 2011 Jun; 28(3):243-52. PubMed ID: 21273283
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells.
    Zu K; Ip C
    Cancer Res; 2003 Oct; 63(20):6988-95. PubMed ID: 14583501
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Vitamin E and its anticancer effects.
    Abraham A; Kattoor AJ; Saldeen T; Mehta JL
    Crit Rev Food Sci Nutr; 2019; 59(17):2831-2838. PubMed ID: 29746786
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
    Albanes D; Till C; Klein EA; Goodman PJ; Mondul AM; Weinstein SJ; Taylor PR; Parnes HL; Gaziano JM; Song X; Fleshner NE; Brown PH; Meyskens FL; Thompson IM
    Cancer Prev Res (Phila); 2014 Sep; 7(9):886-95. PubMed ID: 24961880
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Serum α-tocopherol and γ-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: a nested case-control study.
    Weinstein SJ; Peters U; Ahn J; Friesen MD; Riboli E; Hayes RB; Albanes D
    PLoS One; 2012; 7(7):e40204. PubMed ID: 22792240
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Should finasteride be used to prevent prostate cancer?
    Fleshner N; Kulkarni G
    Curr Treat Options Oncol; 2006 Sep; 7(5):346-54. PubMed ID: 16904051
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Vitamin E and prostate cancer.
    Fleshner NE
    Urol Clin North Am; 2002 Feb; 29(1):107-13, ix. PubMed ID: 12109337
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Vitamin E and prostate cancer: is vitamin E succinate a superior chemopreventive agent?
    Basu A; Imrhan V
    Nutr Rev; 2005 Jul; 63(7):247-51. PubMed ID: 16121478
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial.
    Pak RW; Lanteri VJ; Scheuch JR; Sawczuk IS
    Integr Cancer Ther; 2002 Dec; 1(4):338-44. PubMed ID: 14664728
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The selenium and vitamin E cancer prevention trial.
    Klein EA; Lippman SM; Thompson IM; Goodman PJ; Albanes D; Taylor PR; Coltman C
    World J Urol; 2003 May; 21(1):21-7. PubMed ID: 12756490
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diet, androgens, oxidative stress and prostate cancer susceptibility.
    Fleshner NE; Klotz LH
    Cancer Metastasis Rev; 1998-1999; 17(4):325-30. PubMed ID: 10453275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.